Evidence-Based Benefits
- Osteoarthritis pain reduction — the GUIDE trial (Herrero-Beaumont et al., 2007, n=318) found 1,500mg glucosamine sulfate significantly reduced WOMAC pain scores vs. placebo over 6 months
- Cartilage preservation — the GAIT ancillary study (Sawitzke et al., 2010, n=572) showed glucosamine may slow joint space narrowing over 2 years in moderate-severe OA
- Functional improvement — a Cochrane review (Towheed et al., 2005, 20 RCTs, n=2,570) concluded that Rotta brand glucosamine sulfate improved function in knee osteoarthritis
- Long-term joint protection — Reginster et al. (2001, n=212) demonstrated 3-year glucosamine sulfate use prevented joint space narrowing vs. placebo in knee OA patients
- Anti-inflammatory properties — glucosamine inhibits NF-kB activation and reduces pro-inflammatory cytokine production in cartilage tissue, providing a mechanistic basis for its clinical effects